{{Rsnum
|rsid=10906115
|Chromosome=10
|position=12314997
|Orientation=plus
|GMAF=0.3655
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 40.7 | 46.9 | 12.4
| HCB | 42.3 | 42.3 | 15.3
| JPT | 23.9 | 52.2 | 23.9
| YRI | 59.2 | 34.0 | 6.8
| ASW | 42.9 | 41.1 | 16.1
| CHB | 42.3 | 42.3 | 15.3
| CHD | 38.0 | 49.1 | 13.0
| GIH | 34.7 | 46.5 | 18.8
| LWK | 54.5 | 37.3 | 8.2
| MEX | 29.8 | 50.9 | 19.3
| MKK | 41.3 | 47.1 | 11.6
| TSI | 34.3 | 48.0 | 17.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20862305
|Trait=None
|Title=Identification of new genetic risk variants for type 2 diabetes
|RiskAllele=A
|Pval=1E-8
|OR=1.13
|ORtxt=[1.08-1.18]
|OA=1
}}

{{PMID|21909839}} Genetic variants at CDC123/CAMK1D and SPRY2 are associated with susceptibility to type 2 diabetes in the Japanese population.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}